This Is No Time to Be Buying Pfizer
The company's fairly valued already, and at least one of its blockbuster drugs, Lipitor, is looking vulnerable.
10:38AM 10/23/01
Biogen's Stronger Than It Looks
While its competitors release questionable studies to discredit its drugs, Biogen maintains its lead.
07:38AM 10/09/01
Genentech's Stuck in the Morass for Now
It's got some great drugs waiting in the wings, but they won't be ready anytime soon.
11:44AM 10/01/01
Biotech Could Get Knocked Down a PEG (RealMoney.com $)
The sector's price-to-earnings divided-by-growth ratio is notably high, which could spell a tumble.
09:43AM 07/10/01
Swimming With the Sharks (RealMoney.com $)
Biotech has hit the big time. Suddenly, hard-bitten money managers are buying and selling biotech stocks daily.
01:22PM 06/19/01
For Biotech, Windows Are Reopening (RealMoney.com $)
Investors have ignored genomics companies so far this year. But it looks like that's changing.
08:38PM 05/10/01
Fed Clears the Way for Short-Sellers (RealMoney.com $)
Despite the rate cut, it doesn't get much better than this for biotechs. In fact, it will likely get worse.
03:53PM 04/18/01
Geron Takes Its Knocks, but It Has Assets That Can't Be Ignored (RealMoney.com $)
Dudes, despite what other columnists say, Lissa likes this stock.
04:41PM 03/09/01
One Year Later ... How Is Biotech Doing? (RealMoney.com $)
Biotech fundamentals are fantastic; the only thing hurting the sector is psychology.
06:42PM 03/07/01
Biotech Is Back! (RealMoney.com $)
With fundamentals and technicals bright, this group looks ready for one of its periodic spurts. Any challengers?
09:28AM 02/13/01
Find more premium investing ideas